Miller, Phoebe N.
Romero-Hernandez, Fernanda
Calthorpe, Lucia
Wang, Jaeyun Jane
Kim, Sunhee S.
Corvera, Carlos U.
Hirose, Kenzo
Kirkwood, Kimberly S.
Hirose, Ryutaro
Maker, Ajay V.
Alseidi, Adnan A.
Adam, Mohamed A.
Kim, Grace E.
Tempero, Margaret A.
Ko, Andrew H.
Nakakura, Eric K.
Article History
Received: 9 February 2024
Accepted: 23 May 2024
First Online: 15 June 2024
Disclosures
: Margaret Tempero has held consultancy roles for Astellas Pharma Global Development Inc. (DSMC), AstraZeneca, Bio Ascend-B2ACT Therapeutics Genex, BioSapiens, ElmediX, Debiopharm, Geistlich Pharma, IPSEN Biopharma, Inc., Mirati Therapeutics Inc., Novartis Pharmaceuticals, Oncolytics, Global Bio Access Fund, SAB Peptomyc, S.L., and Geron Corporation; advisory board roles for BeiGene, Biotech Research, Boehringer Ingelheim, Global Bio Access Fund, Merus, and BMS; and served as a Scientific Advisor for Exact Sciences. Phoebe N. Miller, Fernanda Romero-Hernandez, Lucia Calthorpe, Jaeyun Jane Wang, Sunhee S. Kim, Carlos U. Corvera, Kenzo Hirose, Kimberly S. Kirkwood, Ryutaro Hirose, Ajay V. Maker, Adnan A. Alseidi, Mohamed A. Adam, Grace E. Kim, Andrew H. Ko, and Eric K. Nakakura have no conflicts of interest or funding to declare in relation to this work.